Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Libman-Sacks Disease

3,4-methylenedioxyamphetamine has been researched along with Libman-Sacks Disease in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Research Excerpts

ExcerptRelevanceReference
"Individuals with systemic lupus erythematosus (SLE) often experience symptoms that affect family relationships, which are important components of quality of life."1.38Assessment of health-related family role functioning in systemic lupus erythematosus: preliminary validation of a new measure. ( Buyske, S; Hassett, AL; Katz, PP; Li, T; Radvanski, DC; Savage, SV; Schiff, SA, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hassett, AL1
Li, T1
Radvanski, DC1
Savage, SV1
Buyske, S1
Schiff, SA1
Katz, PP1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Libman-Sacks Disease

ArticleYear
Assessment of health-related family role functioning in systemic lupus erythematosus: preliminary validation of a new measure.
    Arthritis care & research, 2012, Volume: 64, Issue:9

    Topics: Activities of Daily Living; Adult; Family Relations; Fatigue; Female; Humans; Love; Lupus Erythemato

2012